|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ratti M, Lampis A, Ghidini M, Salati M,
Mirchev MB, Valeri N and Hahne JC: MicroRNAs (miRNAs) and long
non-coding RNAs (lncRNAs) as new tools for cancer therapy: first
steps from bench to bedside. Target Oncol. 15:261–278. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gutschner T, Richtig G, Haemmerle M and
Pichler M: From biomarkers to therapeutic targets-the promises and
perils of long non-coding RNAs in cancer. Cancer Metastasis Rev.
37:83–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi X, Zhang W, Nian X, Lu X, Li Y, Liu F,
Wang F, He B, Zhao L, Zhu Y, et al: The previously uncharacterized
lncRNA APP promotes prostate cancer progression by acting as a
competing endogenous RNA. Int J Cancer. 146:475–486. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan J, Fang S, Tian H, Zhou C, Zhao X,
Tian H, He J, Shen W, Meng X, Jin X, et al: lncRNA
JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis
of lung cancer by activating Wnt/β-catenin signaling. Mol Cancer.
19:92020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ba Z, Gu L, Hao S, Wang X, Cheng Z and Nie
G: Downregulation of lncRNA CASC2 facilitates osteosarcoma growth
and invasion through miR-181a. Cell Prolif. 51:e124092018.
View Article : Google Scholar
|
|
8
|
Shen B, Zhou N, Hu T, Zhao W, Wu D and
Wang S: LncRNA MEG3 negatively modified osteosarcoma development
through regulation of miR-361-5p and FoxM1. J Cell Physiol.
234:13464–13480. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Z, Wang J, Wang S, Chang H, Zhang T
and Qu J: LncRNA CCAT2 promotes tumorigenesis by over-expressed
Pokemon in non-small cell lung cancer. Biomed Pharmacother.
87:692–697. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Liu L and Zhu W: Up-regulation of
long non-coding RNA CCAT2 correlates with tumor metastasis and poor
prognosis in cervical squamous cell cancer patients. Int J Clin Exp
Pathol. 8:13261–13266. 2015.PubMed/NCBI
|
|
11
|
Zhang J, Jiang Y, Zhu J, Wu T, Ma J, Du C,
Chen S, Li T, Han J and Wang X: Overexpression of long non-coding
RNA colon cancer-associated transcript 2 is associated with
advanced tumor progression and poor prognosis in patients with
colorectal cancer. Oncol Lett. 14:6907–6914. 2017.PubMed/NCBI
|
|
12
|
Ruan R and Zhao XL: LncRNA CCAT2 enhances
cell proliferation via GSK3β/β-catenin signaling pathway in human
osteosarcoma. Eur Rev Med Pharmacol Sci. 22:2978–2984.
2018.PubMed/NCBI
|
|
13
|
Yan L, Wu X, Yin X, Du F, Liu Y and Ding
X: LncRNA CCAT2 promoted osteosarcoma cell proliferation and
invasion. J Cell Mol Med. 22:2592–2599. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang C, Ma K and Li WY: Cinobufagin
suppresses the characteristics of osteosarcoma cancer cells by
inhibiting the IL-6-OPN-STAT3 pathway. Drug Des Devel Ther.
13:4075–4090. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qu H, Xue Y, Lian W, Wang C, He J, Fu Q,
Zhong L, Lin N, Lai L, Ye Z, et al: Melatonin inhibits osteosarcoma
stem cells by suppressing SOX9-mediated signaling. Life Sci.
207:253–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eggers B, Marciniak J, Memmert S, Kramer
FJ, Deschner J and Nokhbehsaim M: The beneficial effect of cold
atmospheric plasma on parameters of molecules and cell function
involved in wound healing in human osteoblast-like cells in vitro.
Odontology. 108:607–616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chu Q, Jiang Y, Zhang W, Xu C, Du W,
Tuguzbaeva G, Qin Y, Li A, Zhang L, Sun G, et al: Pyroptosis is
involved in the pathogenesis of human hepatocellular carcinoma.
Oncotarget. 7:84658–84665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun X, Dai G, Yu L, Hu Q, Chen J and Guo
W: miR-143-3p inhibits the proliferation, migration and invasion in
osteosarcoma by targeting FOSL2. Sci Rep. 8:6062018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Endicott AA, Morimoto LM, Kline CN,
Wiemels JL, Metayer C and Walsh KM: Perinatal factors associated
with clinical presentation of osteosarcoma in children and
adolescents. Pediatr Blood Cancer. 64:642017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strauss SJ and Whelan JS: Current
questions in bone sarcomas. Curr Opin Oncol. 30:252–259. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rasmussen TP: Parallels between artificial
reprogramming and the biogenesis of cancer stem cells: Involvement
of lncRNAs. Semin Cancer Biol. 57:36–44. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rynkeviciene R, Simiene J, Strainiene E,
Stankevicius V, Usinskiene J, Miseikyte Kaubriene E, Meskinyte I,
Cicenas J and Suziedelis K: Non-coding RNAs in glioma. Cancers
(Basel). 11:172018. View Article : Google Scholar
|
|
24
|
Jiang Y, Du W, Chu Q, Qin Y, Tuguzbaeva G,
Wang H, Li A, Li G, Li Y, Chai L, et al: Downregulation of long
non-coding RNA Kcnq1ot1: an important mechanism of arsenic
trioxide-induced long QT syndrome. Cell Physiol Biochem.
45:192–202. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma N, Tie C, Yu B, Zhang W and Wan J:
Identifying lncRNA-miRNA-mRNA networks to investigate Alzheimer's
disease pathogenesis and therapy strategy. Aging (Albany NY).
12:2897–2920. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang X, Ta N, Zhang Y, Gao Y, Hu R, Deng
L, Zhang B, Jiang H and Zheng J: Microarray analysis of the
expression profile of long non-coding RNAs indicates lncRNA
RP11-263F15.1 as a biomarker for diagnosis and prognostic
prediction of pancreatic ductal adenocarcinoma. J Cancer.
8:2740–2755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Wu J, Zhang X, Ding L and Zeng Q:
Microarray analysis of the expression profile of lncRNAs reveals
the key role of lncRNA BC088327 as an agonist to heregulin 1β
induced cell proliferation in peripheral nerve injury. Int J Mol
Med. 41:3477–3484. 2018.PubMed/NCBI
|
|
28
|
Li J, Zhu Y, Wang H and Ji X: Targeting
long noncoding rna in glioma: a pathway perspective. Mol Ther
Nucleic Acids. 13:431–441. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen W, Hang Y, Xu W, Wu J, Chen L, Chen
J, Mao Y, Song J, Song J and Wang H: BLACAT1 predicts poor
prognosis and serves as oncogenic lncRNA in small-cell lung cancer.
J Cell Biochem. 2018.
|
|
30
|
Dai W, Mu L, Cui Y, Li Y, Chen P, Xie H
and Wang X: Berberine promotes apoptosis of colorectal cancer via
regulation of the long non-coding RNA (lncRNA) cancer
susceptibility candidate 2 (CASC2)/AU-binding factor 1
(AUF1)/B-cell CLL/lymphoma 2 (Bcl-2) axis. Med Sci Monit.
25:730–738. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen S, Wu H, Lv N, Wang H, Wang Y, Tang
Q, Shao H and Sun C: LncRNA CCAT2 predicts poor prognosis and
regulates growth and metastasis in small cell lung cancer. Biomed
Pharmacother. 82:583–588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu SW, Hao YP, Qiu JH, Zhang DB, Yu CG and
Li WH: High expression of long non-coding RNA CCAT2 indicates poor
prognosis of gastric cancer and promotes cell proliferation and
invasion. Minerva Med. 108:317–323. 2017.PubMed/NCBI
|
|
34
|
Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ
and Hu JH: Long non-coding RNA CCAT2 is up-regulated in gastric
cancer and associated with poor prognosis. Int J Clin Exp Pathol.
8:779–785. 2015.PubMed/NCBI
|
|
35
|
Zhou N, Si Z, Li T, Chen G, Zhang Z and Qi
H: Long non-coding RNA CCAT2 functions as an oncogene in
hepatocellular carcinoma, regulating cellular proliferation,
migration and apoptosis. Oncol Lett. 12:132–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Y, Wang B, Zhang F, Wang A, Du X, Hu P,
Zhu Y and Fang Z: Long non-coding RNA CCAT2 is associated with poor
prognosis in hepatocellular carcinoma and promotes tumor metastasis
by regulating Snail2-mediated epithelial-mesenchymal transition.
OncoTargets Ther. 10:1191–1198. 2017. View Article : Google Scholar
|
|
37
|
Chen F, Bai G, Li Y, Feng Y and Wang L: A
positive feedback loop of long noncoding RNA CCAT2 and FOXM1
promotes hepatocellular carcinoma growth. Am J Cancer Res.
7:1423–1434. 2017.PubMed/NCBI
|
|
38
|
Yu Y, Nangia-Makker P, Farhana L and
Majumdar APN: A novel mechanism of lncRNA and miRNA interaction:
CCAT2 regulates miR-145 expression by suppressing its maturation
process in colon cancer cells. Mol Cancer. 16:1552017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhu H, Dougherty U, Robinson V, Mustafi R,
Pekow J, Kupfer S, Li YC, Hart J, Goss K, Fichera A, et al: EGFR
signals downregulate tumor suppressors miR-143 and miR-145 in
Western diet-promoted murine colon cancer: Role of G1 regulators.
Mol Cancer Res. 9:960–975. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yan X, Chen X, Liang H, Deng T, Chen W,
Zhang S, Liu M, Gao X, Liu Y, Zhao C, et al: miR-143 and miR-145
synergistically regulate ERBB3 to suppress cell proliferation and
invasion in breast cancer. Mol Cancer. 13:2202014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu Y, Ou Y, Wu K, Chen Y and Sun W:
miR-143 inhibits the metastasis of pancreatic cancer and an
associated signaling pathway. Tumour Biol. 33:1863–1870. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dong X, Lv B, Li Y, Cheng Q, Su C and Yin
G: miR-143 regulates the proliferation and migration of
osteosarcoma cells through targeting MAPK7. Arch Biochem Biophys.
630:47–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Q, Cai J, Wang J, Xiong C and Zhao J:
miR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.
Tumour Biol. 35:12743–12748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu H, Wang H, Liu H and Chen Y: Effect of
miR-143 on the apoptosis of osteosarcoma cells. Int J Clin Exp
Pathol. 8:14241–14246. 2015.PubMed/NCBI
|
